0,996  0,001  Xanthine oxidase inhibitor
0,996  0,001  Monophenol monooxygenase inhibitor
0,995  0,001  Chemoprotective
0,993  0,000  Antimutagenic
0,992  0,002  Mutagenic
0,990  0,000  Chemopreventive
0,986  0,001  Proliferative diseases treatment
0,986  0,003  Alpha-glucosidase inhibitor
0,978  0,000  Amylase inhibitor
0,969  0,000  Antihypoxic
0,968  0,002  Transcription factor NF kappa B inhibitor
0,964  0,001  NOS2 expression inhibitor
0,955  0,002  Antihypercholesterolemic
0,956  0,003  Carcinogenic
0,952  0,001  Caspase 9 stimulant
0,949  0,002  Radioprotector
0,946  0,001  Antidote
0,934  0,002  DNA damaging
0,935  0,003  Antioxidant
0,932  0,001  Melanin inhibitor
0,911  0,001  Cystathionine beta-synthase inhibitor
0,904  0,002  Mediator release inhibitor
0,904  0,003  Antithrombotic
0,898  0,003  Genotoxic
0,896  0,003  Free radical scavenger
0,894  0,003  Vasodilator, coronary
0,893  0,004  TNF expression inhibitor
0,882  0,008  Apoptosis agonist
0,875  0,003  Cardioprotectant
0,875  0,005  Teratogen
0,875  0,007  Antiinflammatory
0,861  0,002  UGT1A1 substrate
0,852  0,003  Antibacterial
0,854  0,005  Embryotoxic
0,833  0,001  Antihemorrhagic
0,818  0,003  Antiamyloidogenic
0,802  0,004  Sensitization
0,796  0,007  Cyclophilin D inhibitor
0,796  0,007  Antidiabetic
0,788  0,004  Nitric oxide antagonist
0,783  0,002  VCAM1 expression inhibitor
0,779  0,002  Carbonic anhydrase XIII inhibitor
0,765  0,003  Antiparasitic
0,766  0,004  UGT1A9 substrate
0,765  0,004  Cytotoxic
0,756  0,002  Antihelmintic
0,752  0,004  Vascular (periferal) disease treatment
0,752  0,004  Hypoglycemic
0,748  0,003  Antihypotensive
0,744  0,002  Beta glucuronidase inhibitor
0,746  0,004  Angiogenesis stimulant
0,750  0,009  Antileukemic
0,741  0,004  AR expression inhibitor
0,740  0,004  Antihypertriglyceridemic
0,736  0,004  Antipyretic
0,742  0,015  Antineoplastic (breast cancer)
0,731  0,005  Caspase 3 stimulant
0,727  0,004  Apoptosis antagonist
0,722  0,007  Cytostatic
0,721  0,007  Immunostimulant
0,720  0,016  Antineoplastic (lung cancer)
0,707  0,005  Tumour necrosis factor alpha release inhibitor
0,705  0,003  NOS3 expression enhancer
0,693  0,004  Sulfotransferase substrate
0,692  0,004  Skin whitener
0,692  0,006  NOS3 expression inhibitor
0,689  0,005  Hepatic disorders treatment
0,685  0,015  Antineoplastic (colorectal cancer)
0,672  0,005  Antipruritic, allergic
0,666  0,004  Hepatoprotectant
0,668  0,010  Cholesterol antagonist
0,657  0,005  UDP-glucuronosyltransferase substrate
0,651  0,002  Protein kinase stimulant
0,650  0,005  Ulceration
0,646  0,009  Spasmolytic
0,652  0,017  Antineoplastic (colon cancer)
0,650  0,016  CYP2C9 substrate
0,626  0,005  Antineoplastic (osteosarcoma)
0,627  0,007  Amyloid beta aggregation inhibitor
0,641  0,024  CYP3A4 substrate
0,615  0,003  Hemostatic
0,623  0,012  Antineoplastic (cervical cancer)
0,611  0,004  ICAM1 expression inhibitor
0,609  0,008  Antiprotozoal (Leishmania)
0,602  0,008  Antifungal
0,602  0,015  Antineoplastic (ovarian cancer)
0,581  0,004  Alkylator
0,588  0,015  Immunosuppressant
0,573  0,003  Alcohol dehydrogenase inhibitor
0,583  0,020  Prostate cancer treatment
0,549  0,004  Lipid peroxidase inhibitor
0,559  0,017  Antineoplastic (melanoma)
0,545  0,005  Radiosensitizer
0,559  0,018  Stroke treatment
0,555  0,016  Antineoplastic (pancreatic cancer)
0,546  0,010  UGT1A6 substrate
0,537  0,004  Antifungal enhancer
0,544  0,017  Histamine release inhibitor
0,528  0,009  Antineoplastic (lymphoma)
0,517  0,005  Platelet adhesion inhibitor
0,520  0,010  Vasodilator
0,512  0,006  Non-steroidal antiinflammatory agent
0,509  0,003  AMP-activated protein kinase stimulant
0,520  0,016  Antineoplastic (multiple myeloma)
0,502  0,006  Topoisomerase II inhibitor
0,495  0,006  Interferon gamma antagonist
0,489  0,011  RNA-directed DNA polymerase inhibitor
0,486  0,009  Antineoplastic (sarcoma)
0,479  0,003  Selectin antagonist
0,495  0,024  Immunomodulator
0,489  0,021  Antineoplastic (brain cancer)
0,488  0,020  Antineoplastic (glioma)
0,479  0,011  Antineoplastic (liver cancer)
0,495  0,050  Alzheimer's disease treatment
0,458  0,018  UGT2B4 substrate
0,449  0,012  P-glycoprotein inhibitor
0,447  0,010  Antiviral (Herpes)
0,452  0,020  Antineoplastic (glioblastoma multiforme)
0,448  0,017  DNA synthesis inhibitor
0,445  0,016  Antineoplastic enhancer
0,444  0,017  Interleukin 2 agonist
0,436  0,012  Septic shock treatment
0,424  0,004  Dementia treatment
0,422  0,004  Expectorant
0,442  0,025  Antineoplastic (non-small cell lung cancer)
0,421  0,004  Vascular dementia treatment
0,431  0,018  Antineoplastic (renal cancer)
0,428  0,017  Myocardial infarction treatment
0,415  0,004  Antihelmintic (Nematodes)
0,444  0,037  Respiratory analeptic
0,430  0,024  Hypoxia-inducible factor 1 alpha inhibitor
0,433  0,032  Antiischemic
0,404  0,011  Antineoplastic (squamous cell carcinoma)
0,403  0,010  Antiviral (Influenza)
0,422  0,034  Lipoprotein disorders treatment
0,440  0,053  Antiprotozoal
0,389  0,004  Nitric-oxide synthase stimulant
0,388  0,005  Antibiotic
0,387  0,005  Topoisomerase II alpha inhibitor
0,404  0,024  Antidiabetic symptomatic
0,399  0,020  Antiulcerative
0,414  0,036  Antimycobacterial
0,378  0,006  Antineoplastic antibiotic
0,370  0,005  Interleukin 4 antagonist
0,349  0,006  Aldose reductase substrate
0,430  0,090  Antineoplastic (solid tumors)
0,351  0,012  Peptidyltransferase inhibitor
0,344  0,008  Topoisomerase I inhibitor
0,341  0,010  Acute respiratory distress syndrome (ARDS) treatment
0,373  0,043  CTGF expression inhibitor
0,335  0,008  Antitussive
0,408  0,089  Antiarthritic
0,336  0,018  Antineoplastic (carcinoma)
0,340  0,032  Antineoplastic (lymphocytic leukemia)
0,317  0,018  Restenosis treatment
0,302  0,004  Aldose reductase inhibitor
0,360  0,067  Angiogenesis inhibitor
0,338  0,047  Antidiabetic (type 2)
0,341  0,052  Antiosteoporotic
0,297  0,010  Cell wall synthesis inhibitor
0,330  0,047  Antineoplastic (small cell lung cancer)
0,291  0,011  Cell adhesion inhibitor
0,295  0,015  Interleukin 6 antagonist
0,296  0,017  Antiviral (Influenza A)
0,334  0,056  CYP1A2 substrate
0,290  0,014  Antidiarrheal
0,340  0,069  Bone diseases treatment
0,274  0,004  Carbonic anhydrase XIV inhibitor
0,277  0,007  Carbonic anhydrase VI inhibitor
0,309  0,043  Interleukin agonist
0,319  0,053  Huntington's disease treatment
0,273  0,007  Cyclooxygenase 3 inhibitor
0,284  0,020  Insulin sensitizer
0,265  0,008  Carbonic anhydrase III inhibitor
0,265  0,008  Antifungal (Cryptococcus)
0,304  0,047  Hypolipemic
0,320  0,064  Analeptic
0,258  0,003  Phosphodiesterase 6D inhibitor
0,281  0,027  Thrombolytic
0,257  0,004  Toll-Like receptor 4 antagonist
0,310  0,062  CYP2C19 substrate
0,272  0,025  Protein-tyrosine phosphatase inhibitor
0,256  0,012  ATPase inhibitor
0,260  0,018  Insulin secretagoues
0,275  0,036  DNA methylase inhibitor
0,243  0,007  Photosensitizer
0,290  0,056  Platelet antagonist
0,304  0,071  Antineoplastic (endocrine cancer)
0,239  0,006  DNA repair enzyme inhibitor
0,246  0,015  Gout treatment
0,270  0,042  Wound healing agent
0,284  0,065  Transcription factor STAT inhibitor
0,253  0,034  Antipruritic, non-allergic
0,245  0,027  Liver fibrosis treatment
0,289  0,071  Antituberculosic
0,229  0,012  Choleretic
0,248  0,031  UGT1A3 substrate
0,235  0,019  Chelator
0,243  0,029  UGT2B15 substrate
0,231  0,021  Glutathione S-transferase substrate
0,215  0,008  Antiviral (Influenza B)
0,226  0,022  Protein-tyrosine phosphatase 1B inhibitor
0,213  0,009  HIV-1 integrase (3'-Processing) inhibitor
0,207  0,004  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,261  0,058  Interleukin antagonist
0,235  0,034  Antineoplastic (gastric cancer)
0,206  0,005  Interleukin 12 antagonist
0,203  0,002  Na+ K+ transporting ATPase inhibitor
0,211  0,011  Antihelmintic (Trematoda)
0,243  0,043  Neurotrophic factor enhancer
0,244  0,045  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,217  0,018  Antibacterial (Helicobacter pylori)
0,217  0,021  DNA intercalator
0,203  0,008  Carbonic anhydrase XII inhibitor
0,202  0,009  HIV-1 integrase (Strand Transfer) inhibitor
0,193  0,004  Antibiotic Glycopeptide-like
0,191  0,005  Xanthine dehydrogenase inhibitor
0,220  0,036  Antiacne
0,184  0,005  Carbonic anhydrase VII inhibitor
0,193  0,014  Uric acid excretion stimulant
0,204  0,027  DNA polymerase I inhibitor
0,175  0,005  Protein 50S ribosomal subunit inhibitor
0,186  0,016  Gastritis treatment
0,198  0,029  Psychosexual dysfunction treatment
0,178  0,011  Transcription factor NF kappa B stimulant
0,176  0,011  Thioredoxin inhibitor
0,186  0,021  Growth stimulant
0,179  0,017  Antispirochetal
0,168  0,007  Histone deacetylase stimulant
0,168  0,007  Histone deacetylase SIRT1 stimulant
0,210  0,055  Sepsis treatment
0,155  0,002  Cholesterol absorption inhibitor
0,180  0,027  Carcinogenic, group 2B
0,170  0,020  HDL-cholesterol increasing
0,151  0,002  Arginase inhibitor
0,270  0,121  Antiprotozoal (Plasmodium)
0,193  0,045  Antineoplastic (bone cancer)
0,172  0,027  Beta amyloid protein antagonist
0,184  0,040  Antinephritic
0,204  0,060  UGT2B7 substrate
0,183  0,041  Antiprotozoal (Coccidial)
0,162  0,020  Multidrug resistance-associated protein 1 inhibitor
0,217  0,078  Antiviral (HIV)
0,146  0,007  Phosphodiesterase VI inhibitor
0,138  0,005  Antimycoplasmal
0,164  0,031  Microtubule formation inhibitor
0,187  0,055  Antirickettsial
0,158  0,028  Antineoplastic (uterine cancer)
0,180  0,050  Cyclooxygenase inhibitor
0,203  0,079  Pyruvate kinase inhibitor
0,226  0,103  Antineoplastic (bladder cancer)
0,170  0,048  Cyclooxygenase 1 inhibitor
0,134  0,012  ATPase (Vacuolar H+) inhibitor
0,161  0,040  Antiviral (Hepatitis B)
0,132  0,014  Lipase inhibitor
0,163  0,045  Cyclooxygenase 2 inhibitor
0,220  0,103  Antiprotozoal (Trypanosoma)
0,140  0,028  Estrogen antagonist
0,160  0,051  Neurotrophic factor
0,151  0,043  Heat shock protein 70 antagonist
0,118  0,015  T cell inhibitor
0,116  0,014  Estrogen agonist
0,187  0,086  Antiviral (Ebola)
0,104  0,005  Glucose-6-phosphate translocase inhibitor
0,110  0,014  Neuraminidase (influenza) inhibitor
0,176  0,082  DNA methyltransferase I inhibitor
0,149  0,056  Acetylcholinesterase inhibitor
0,095  0,003  Sodium/glucose cotransporter 2 inhibitor
0,120  0,029  NAD(P)H dehydrogenase (quinone) inhibitor
0,121  0,029  SULT1E1 substrate
0,139  0,048  Interleukin 1b antagonist
0,128  0,038  Chronic obstructive bronchitis treatment
0,119  0,029  Antiviral (Rhinovirus)
0,140  0,050  Vanilloid 1 agonist
0,101  0,015  Antitreponemal
0,089  0,004  Antibiotic Aminoglycoside-like
0,106  0,022  Antiviral (Dengue virus)
0,208  0,124  Transcription factor STAT3 inhibitor
0,130  0,046  Mucolytic
0,113  0,029  Interleukin 5 antagonist
0,105  0,022  HIV-1 integrase inhibitor
0,087  0,005  Heparanase inhibitor
0,110  0,031  Antiviral (Trachoma)
0,081  0,003  Sodium/glucose cotransporter inhibitor
0,078  0,004  Protein 30S ribosomal subunit inhibitor
0,092  0,019  Neuraminidase inhibitor
0,086  0,017  Nitric oxide donor
0,133  0,065  Retinoprotector
0,098  0,030  Thioredoxin reductase inhibitor
0,095  0,033  Interferon agonist
0,092  0,032  CDC25A inhibitor
0,110  0,051  UDP-glucose 4-epimerase inhibitor
0,084  0,025  CDC25B inhibitor
0,101  0,043  NADH dehydrogenase inhibitor
0,092  0,035  Phosphofructokinase-1 inhibitor
0,080  0,024  Maillard reaction inhibitor
0,141  0,087  Eye irritation, high
0,068  0,017  Adenine nucleotide translocase inhibitor
0,128  0,078  Alkaline phosphatase inhibitor
0,101  0,052  Falcipain 2 inhibitor
0,101  0,054  Falcipain inhibitor
0,129  0,084  Hair growth stimulant
0,087  0,045  Cell adhesion molecule inhibitor
0,180  0,141  5 Hydroxytryptamine release stimulant
0,043  0,005  Sodium/glucose cotransporter 1 inhibitor
0,066  0,029  Fatty acid synthase inhibitor
0,065  0,029  Postmenopausal disorders treatment
0,056  0,023  Factor III inhibitor
0,204  0,171  Vasodilator, peripheral
0,193  0,163  Metabolic disease treatment
0,092  0,063  Antineoplastic, alkylator
0,227  0,199  CYP2C19 inhibitor
0,097  0,069  Estrogen receptor beta antagonist
0,065  0,037  Prostaglandin EP2 antagonist
0,066  0,040  Interferon inducer
0,221  0,195  Atherosclerosis treatment
0,034  0,008  Toll-Like receptor 4 agonist
0,052  0,026  Microtubule stabilization
0,117  0,093  Interleukin 1 antagonist
0,105  0,081  Carcinogenic, group 3
0,127  0,104  Anticoagulant
0,181  0,162  CYP2D6 substrate
0,023  0,006  Antibiotic Macrolide-like
0,103  0,088  M18 aspartyl aminopeptidase inhibitor
0,053  0,038  Leukotriene B4 antagonist
0,030  0,015  1,3-Beta-glucan synthase inhibitor
0,049  0,036  Equilibrative nucleoside transport protein inhibitor
0,021  0,009  Antibiotic Anthracycline-like
0,098  0,090  Cholesterol synthesis inhibitor
0,219  0,215  Antiparkinsonian
0,127  0,124  Diabetic retinopathy treatment
0,080  0,078  Actinic keratosis treatment
0,040  0,037  Phosphorylase inhibitor
0,116  0,114  SULT1A3 substrate

